The Journal of Immunology, Vol 153, Issue 11 4959-4968, Copyright © 1994 by American Association of Immunologists

ARTICLES

Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease

RR Leibnitz, PE Lipsky and DL Thiele
Immunology Graduate Program, University of Texas Southwestern Medical Center at Dallas 75235.

To examine the specificity of T helper cells activated during murine graft-vs-host disease (GVHD), T cell hybridomas from GVHD spleens and livers were generated and analyzed. CTL-depleted C57BL/6 (B6) donor cells were injected into irradiated (B6 x bm12)F1 or (bm1 x bm12)F1 recipient mice. Five or fourteen days later, cells from livers and spleens were fused directly with the TCR-deficient (alpha beta)- BW5147 thymoma line. The in vivo-activated T cells produced hybridomas as efficiently as either T cells activated in a primary mixed lymphocyte reaction or expanded in vitro after isolation from GVHD mice. Overall, 91% (396 of 437) of hybridomas generated from GVHD animals responded to immobilized anti-CD3 and 56% (220 of 396) of these hybridomas responded specifically to APC expressing host bm1 or bm12 alloantigens. More than 80% of bm12-specific hybridomas expressed CD4; all (53 of 53) of the bm12-specific hybridomas tested reacted to homozygous bm12 APC. Of the alloreactive T hybridomas generated from B6-->(bm1 x bm12)F1 GVHD mice, 7% responded to bm1 APC. Five bm1-specific hybridomas were analyzed further. One CD4+ hybridoma recognized a bm1 peptide presented by self I-Ab and was blocked by anti-Ia Ab; the other four hybridomas, two of which also expressed CD4, responded to transfected L cells expressing H- 2Kbm1 and were not inhibited by anti-Ia Ab. These results indicate that a high percentage of CD4+ T hybridomas generated from freshly isolated T cells activated in vivo during GVHD are specific for host MHC class II or class I alloantigens.

This article has been cited by other articles:

				G. R. Brown, E. L. Lee, and D. L. Thiele TNF Enhances CD4+ T Cell Alloproliferation, IFN-{gamma} Responses, and Intestinal Graft-Versus-Host Disease by IL-12-Independent Mechanisms J. Immunol., May 15, 2003; 170(10): 5082 - 5088. [Abstract] [Full Text] [PDF]

				G. R. Brown, E. Lee, and D. L. Thiele TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J->C57BL/6J x bm12)F1 Mice J. Immunol., March 15, 2002; 168(6): 3065 - 3071. [Abstract] [Full Text] [PDF]

				W. R. Drobyski, H. C. Morse III, W. H. Burns, J. T. Casper, and G. Sandford Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene Blood, April 15, 2001; 97(8): 2506 - 2513. [Abstract] [Full Text] [PDF]

				J. L. Cohen, O. Boyer, B. Salomon, R. Onclercq, F. Charlotte, S. Bruel, G. Boisserie, and D. Klatzmann Prevention of Graft-Versus-Host Disease in Mice Using a Suicide Gene Expressed in T Lymphocytes Blood, June 15, 1997; 89(12): 4636 - 4645. [Abstract] [Full Text] [PDF]